The Documents · Section 5 of 5
Regulatory and funding decisions, each one a document with a date: an enforcement policy, a consultation, an assessment, a statement.
Start here
The US Federal Trade Commission's November 2016 enforcement policy statement on homeopathic product claims — what it requires on labels, the 'competent and reliable scientific evidence' standard, and examples of the disclosure language it mandated.
Read it
EASAC's 2017 statement on homeopathic products — the member academies who endorsed it, its scope, and the specific regulatory recommendations it directed at EU institutions.
The DocumentsThe NHS England consultation on items of low clinical value (July 2017) — homeopathy's inclusion, the volume of responses, the final guidance published in November 2017, and the end of routine CCG funding that followed in 2018.
The DocumentsThe French Haute Autorité de Santé's 2019 assessment, the government announcement of the phased withdrawal of Sécurité Sociale reimbursement for homeopathic products, and the completion of that withdrawal in 2021.
The Documents
